Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: TRIGR - Trial to Reduce IDDM in the Genetically at Risk
Brief Summary: The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) is an international effort to conduct a primary prevention nutrition trial for type 1 (insulin-dependent) diabetes. The TRIGR study was targeted at newborns who are at genetic risk for type 1 diabetes because their mother, father and/or full sibling has type 1 diabetes. All families were encouraged to breast feed their infants for as long as possible. Prior to birth, the child was randomly assigned to receive one of two infant formulas, should formula be required prior to 8 months of age. The study determined whether weaning to a possibly protective infant formula decreases these children's chances of developing diabetes - as it does in the animal models for diabetes.


Options:
A: Arm Label: Group EEEEEEE; Type: ACTIVE_COMPARATOR; Interventions: Other: Enfamil, milk-based formula | Arm Label: Group ENEEEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group EENEEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group EEENEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group ENNNEEE; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Arm Label: Group NNNNNNN; Type: EXPERIMENTAL; Interventions: Other: Nutramigen (Flavor and Type of Infant Formula) | Intervention Type: OTHER; Name: Nutramigen (Flavor and Type of Infant Formula); Assigned to Arm(s): Group EEENEEE, Group EENEEEE, Group ENEEEEE, Group ENNNEEE, Group NNNNNNN | Intervention Type: OTHER; Name: Enfamil, milk-based formula; Assigned to Arm(s): Group EEEEEEE
B: Arm Label: A highly hydrolyzed casein formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: A highly hydrolyzed formula | Arm Label: A conventiona cow's milk based formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: A regular cow's milk based formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A highly hydrolyzed formula; Assigned to Arm(s): A highly hydrolyzed casein formula | Intervention Type: DIETARY_SUPPLEMENT; Name: A regular cow's milk based formula; Assigned to Arm(s): A conventiona cow's milk based formula
C: Arm Label: Hydrolysed infant formula; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Hydrolysed infant formula | Arm Label: Nonhydrolysed infant formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Nonhydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Hydrolysed infant formula; Assigned to Arm(s): Hydrolysed infant formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Nonhydrolysed infant formula; Assigned to Arm(s): Nonhydrolysed infant formula
D: Arm Label: Cow's milk formula; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Bovine insulin-free whey based formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Arm Label: Whey-based hydrolysed formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cow's milk formula | Intervention Type: DIETARY_SUPPLEMENT; Name: Cow's milk formula; Assigned to Arm(s): Bovine insulin-free whey based formula, Cow's milk formula, Whey-based hydrolysed formula

Answer: C